to support the clinical investigation of MT-601 in patients with metastatic pancreatic cancer HOUSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage ...

Dolphins in ancient Greece were revered as messengers of the gods and held a divine dimension that has survived through the ...

Intech Investment Management LLC reduced its position in shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 11.8% during the 4th quarter, HoldingsChannel reports.

Vast Therapeutics, a clinical-stage life science company, today announced that the U.S. Food and Drug Administration has ...

Institutional investors own 4.61% of the company’s stock. Summit Therapeutics Inc, a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician ...

(TENX) on Tuesday reported a loss of $6.3 million in its fourth quarter. On a per-share basis, the Chapel Hill, North Carolina-based company said it had a loss of 18 cents.

A house fire has been reported on Clovernook Avenue in Mt. Healthy. The extent of the fire has not been confirmed. However, ...

Several replacements to water mains in the city of Missoula will close streets over the next several weeks, with one main ...

Celebrations have been held at Goldenhill Medical Centre - after a long-serving GP finally hung up his stephoscope following ...